GlassScriptPhysician profile
Ashley M Cobert
NPI 1346648839
$5,169.26
in general payments reported to CMS, 2019-2025
41 companies · $1,706 in 2025
The $1,706 reported for 2025 was more than what 89% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $279 · 2022: $586 · 2023: $767 · 2024: $1,831 · 2025: $1,706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,304.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,126.18 | 2022-2025 | Jardiance, Mounjaro, Zepbound |
| Beta Bionics, INC. | $406.72 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Novo Nordisk INC | $400.89 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $307.16 | 2021-2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $236.75 | 2021-2025 | Jardiance |
| Corcept Therapeutics | $203.08 | 2023-2025 | Korlym |
| Radius Health, INC. | $185.80 | 2022-2025 | Tymlos |
| Amgen INC. | $167.01 | 2023-2025 | Evenity, Prolia, Tepezza |
| Sequel Med Tech, LLC | $152.60 | 2025 | Twiist |
| Xeris Pharmaceuticals, INC. | $150.12 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Abbvie INC. | $145.32 | 2021-2024 | |
| Amneal Pharmaceuticals LLC | $143.72 | 2022-2025 | Unithroid |
| Antares Pharma, INC. | $140.32 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Abbott Laboratories | $137.40 | 2024-2025 | Freestyle Libre 3 |
| Intuity Medical INC | $131.27 | 2022 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $129.29 | 2023-2025 | Strensiq |
| Bayer Healthcare Pharmaceuticals INC. | $119.32 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $93.77 | 2021-2025 | |
| Insulet Corporation | $92.93 | 2021-2025 | Omnipod |
| Tandem Diabetes Care, INC. | $64.34 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic, INC. | $58.63 | 2023-2025 | Intellis Adaptivestim, Minimed 780g |
| Halozyme INC | $54.91 | 2023 | |
| Kyowa Kirin, INC. | $54.36 | 2024 | Crysvita |
| Amryt Pharma Holdings LTD | $48.02 | 2023 | Mycapssa |
| Astellas Pharma US INC | $43.14 | 2025 | Veozah |
| Astrazeneca Pharmaceuticals LP | $41.14 | 2022-2024 | Farxiga |
| Mannkind Corporation | $36.74 | 2024 | |
| Amphastar Pharmaceuticals, INC. | $32.63 | 2025 | |
| Sandoz INC. | $30.98 | 2025 | |
| Cequr Corporation | $27.32 | 2024 | Cequr Simplicity |
| Chiesi USA, INC. | $23.96 | 2025 | Myalept |
| Ascensia Diabetes Care US INC. | $23.51 | 2024 | |
| Zealand Pharma US, INC. | $21.81 | 2021 | |
| Inspire Medical Systems, INC. | $19.66 | 2025 | Inspire |
| Averitas Pharma INC. | $19.53 | 2024 | Qutenza |
| Horizon Therapeutics Plc | $19.43 | 2022 | |
| Tolmar, INC. | $17.63 | 2025 | Jatenzo |
| Ionis Pharmaceuticals, INC. | $17.03 | 2025 | Tryngolza |
| Boston Scientific Corporation | $15.68 | 2021 | |
| Verity Pharmaceuticals INC. | $15.26 | 2025 | Tlando |
| Clarus Therapeutics INC. | $13.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Cobert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.